Get the full aitiologic company profile
Access contacts, investors, buying signals & more
Austrian precision medicine startup aitiologic, which develops AI-powered solutions for early disease detection and targeted therapy, has closed a $7.4M Seed funding round.
The investment drew support from a syndicate of investors including Heal Capital, Ananda Impact Ventures, PUSH, and LANA Ventures. Individual investor Gordon Sanghera also participated in the round.
When we founded Aitiologic, we set out to answer a question: How much more could a blood sample tell us if we could better interpret the DNA it contains? Today, we’re announcing an oversubscribed €6.4 million seed round to advance that ambition, co-led by Heal Capital and Ananda Impact Ventures.
Our Aitios® platform combines molecular signals from individual cell-free DNA molecules with AI to infer their tissue of origin and reveal tissue-specific biological changes. We’re starting with preeclampsia: identifying risk in the first trimester, using the same blood sample routinely collected for non-invasive prenatal testing. Earlier insight into maternal and placental health, without an add
Epitome Therapeutics
Epitome Therapeutics is a biotechnology company advancing precision epigenome editing for programmable gene expression. Founded in 2025 as a spin-off from EMBL, Epitome is developing CADENCE, a next-generation platform designed to enable the precise and durable calibration of gene dosage without altering the underlying DNA sequence. The company aims to establish new therapeutic approaches for diseases driven by dysregulated gene activity, including rare and metabolic disorders.
$2.3M Pre-seed
1 month ago
Loom Ventures
We invest in European early-stage companies that make infrastructure more autonomous, capable, and resilient. STRABAG, one of Europe's largest infrastructure groups, is our investor and partner. This gives us and our founders direct industry access and domain expertise.
$108.0M Unknown
1 month ago
Largest funding rounds in AI on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Nuance Healthcare United States | Unknown | $19.7B | 2y ago |
| 2 |  OpenAI United States | Unknown | $13.0B |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  EnforceShield Lithuania | Seed | $2.0M | today |
| 2 |  Zero Finland | Seed | $10.4M | today |
| 3 |
Mobius Bio
Mobius is a discovery stage biotech utilising a unique, clinically validated platform to identify and develop novel anticancer drugs. Our vision is to systematically go beyond the mouse and discover molecules rooted in a deep understanding of human biology, not animal models, to deliver medicines designed to succeed in the clinic. We do this by integrating frontier AI capabilities, deep disease insights and a proprietary wet lab platform, which allows us to interrogate disease mechanisms directly in live human tissue samples with proven clinical relevance. We are an international team of dedicated drug hunters, engineers and entrepreneurs determined to bring transformative treatments to patients with high unmet medical needs.
$30.0M Unknown
1 month ago
| 2y ago |
| 3 | Anthropic United States | Series f | $13.0B | 1y ago |
| 4 |  AIMAX United Kingdom | Unknown | $10.0B | 2y ago |
| 5 |  Preferred Networks, Inc. Japan | Unknown | ¥10.0B | 1y ago |
Zero Finland |
| Seed |
| $10.4M |
| today |
| 4 |  TOPAS Solutions Inc | Seed | $1.0M | today |
| 5 |  Custodea 🇪🇺 The Netherlands | Seed | $406.9K | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
Heal Capital
VC FIRM
Ananda Impact Ventures
VC FIRM
Unlock 3 more investors and reach their contacts directly.
Start free trialUnlock aitiologic's full leadership team with verified emails and LinkedIn.
Start free trial
OriginalVoices
Recently received
.png&w=3840&q=75)
TesterArmy (YC P26)
Recently received
EnforceShield
Recently received
